FANTACUZZI, MARIALUIGIA
 Distribuzione geografica
Continente #
NA - Nord America 3.845
EU - Europa 3.023
AS - Asia 2.590
SA - Sud America 278
AF - Africa 38
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 9.778
Nazione #
US - Stati Uniti d'America 3.734
SG - Singapore 922
CN - Cina 807
IT - Italia 773
IE - Irlanda 413
TR - Turchia 380
UA - Ucraina 350
SE - Svezia 347
FR - Francia 250
BR - Brasile 247
GB - Regno Unito 237
IN - India 219
DE - Germania 190
PL - Polonia 125
VN - Vietnam 119
FI - Finlandia 102
CA - Canada 77
RU - Federazione Russa 59
ES - Italia 34
AT - Austria 32
CZ - Repubblica Ceca 24
MX - Messico 23
NL - Olanda 23
JP - Giappone 22
BE - Belgio 21
HK - Hong Kong 21
BD - Bangladesh 19
ZA - Sudafrica 18
LT - Lituania 15
PT - Portogallo 12
AR - Argentina 10
KR - Corea 10
ID - Indonesia 8
IQ - Iraq 8
PH - Filippine 7
PK - Pakistan 7
VE - Venezuela 6
CL - Cile 5
DZ - Algeria 5
HR - Croazia 5
SA - Arabia Saudita 5
TW - Taiwan 5
AE - Emirati Arabi Uniti 4
EG - Egitto 4
GR - Grecia 4
IR - Iran 4
PE - Perù 4
EC - Ecuador 3
ET - Etiopia 3
KE - Kenya 3
MY - Malesia 3
YE - Yemen 3
AL - Albania 2
AU - Australia 2
CH - Svizzera 2
CR - Costa Rica 2
IL - Israele 2
JM - Giamaica 2
JO - Giordania 2
LB - Libano 2
MA - Marocco 2
PY - Paraguay 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EU - Europa 1
GD - Grenada 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
MM - Myanmar 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TN - Tunisia 1
UY - Uruguay 1
UZ - Uzbekistan 1
ZW - Zimbabwe 1
Totale 9.778
Città #
Singapore 679
Chandler 501
Jacksonville 429
Dublin 407
Ashburn 283
Dallas 248
Izmir 244
Dearborn 210
Chieti 209
Beijing 203
Princeton 169
Southend 148
Nanjing 128
The Dalles 116
Los Angeles 110
Kraków 89
Santa Clara 89
Cambridge 82
Ann Arbor 79
Wilmington 69
Nanchang 63
New York 63
Munich 55
Altamura 49
Tongling 48
Ho Chi Minh City 42
Buffalo 36
Warsaw 34
Boardman 33
Pescara 32
São Paulo 32
Hebei 31
Bosa 30
Shenyang 30
Teramo 30
Redondo Beach 27
Helsinki 26
Jiaxing 25
Denver 24
Brno 23
Jinan 23
Kunming 22
Washington 22
Brooklyn 21
Brussels 21
Vienna 21
Atlanta 20
Ottawa 20
Stockholm 20
Tianjin 20
Changsha 19
Chennai 19
Rome 19
Toronto 19
Hanoi 18
Hong Kong 18
London 18
Milan 18
Kocaeli 17
Orem 17
Tokyo 17
Hefei 16
Houston 15
Amsterdam 14
Montreal 14
Turku 14
Johannesburg 13
Poplar 13
Woodbridge 13
Chicago 11
Hangzhou 11
Nuremberg 11
Ankara 10
Manchester 10
Norwalk 10
San Francisco 10
Augusta 9
Falls Church 9
Mexico City 9
Ningbo 9
Biên Hòa 8
Dong Ket 8
Porto 8
Redwood City 8
Seattle 8
Zhengzhou 8
Belo Horizonte 7
Changchun 7
Como 7
Guangzhou 7
Haiphong 7
Nogarole Vicentino 7
Phoenix 7
Rio de Janeiro 7
San Mateo 7
San Vito Chietino 7
Bari 6
Bologna 6
Brasília 6
Moscow 6
Totale 5.997
Nome #
Synthesis of 2-aryloxypropanoic acids analogues of clofibric acid and assignment of the absolute configuration by 1H NMR spectroscopy and DFT calculations 174
Discovery of N-{3-[(ethanimidoylamino)methyl]benzyl}-L-prolinamide dihydrochloride: A new potent and selective inhibitor of the inducible nitric oxide synthase as a promising agent for the therapy of malignant glioma 170
Synthesis and antibacterial evaluation of oxazolidin-2-ones structurally related to linezolid 167
Anticancer Activity of Stilbene-Based Derivatives 158
Titanium-Promoted Acylation of Sulfonamides to N-Acylsulfonamide PPAR Antagonists 154
Synthesis, biological activity, and docking studies of novel acetamidines as selective modulators of nitric oxide synthase 150
Synthesis and structure-activity relationships of fibrate-based analogues inside PPARs 150
Synthesis and biological evaluation of potential Nitric Oxide Synthase inhibitors 149
Valutazione biologica dei derivati dell'acido clofibrico come potenziali ligandi PPARs 148
Synthesis and Biological Evaluation of 2-Heteroarylthioalkanoic Acid Analogues of Clofibric Acid as Peroxisome Proliferator-Activated Receptor alfa Agonists 147
Recent developments of amidine-like compounds as selective NOS inhibitors 139
Antiglioma Activity of Aryl and Amido-Aryl Acetamidine Derivatives Targeting iNOS: Synthesis and Biological Evaluation 139
Cytotoxic effect of a family of Peroxisome Proliferator-Activated Receptor antagonists in colorectal and pancreatic cancer cell lines 138
Novel Phenyldiazenyl Fibrate Analogues as PPAR α/γ/δ Pan-Agonists for the Amelioration of Metabolic Syndrome 138
Candida rugosa lipase-catalysed kinetic resolution of 2-substituted-aryloxyacetic esters with dimethylsulfoxide and isopropanol as additives 136
Asymmetric Synthesis of Arylpropionic Acids and Aryloxy Acids by Using Lactamides as Chiral Auxiliaries 136
Discovery of new FXR agonists based on 6-ECDCA binding properties by virtual screening and molecular docking 135
The Selective Acetamidine-Based iNOS Inhibitor CM544 Reduces Glioma Cell Proliferation by Enhancing PARP-1 Cleavage In Vitro 132
Enantiomeric separation of Gemfibrozil chiral analogues by capillary electrophoresis with heptakis(2,3,6-tri-O-methyl)-beta-cyclodextrin as chiral selector 131
Synthesis and biological evaluation of gemfibrozil chiral analogs as potential PPARa agonists 131
Synthesis and biological characterization of 3-(imidazol-1-ylmethyl)piperidine sulfonamides as aromatase inhibitors 130
PPARα agonists based on stilbene and its bioisosteres: Biological evaluation and docking studies 129
Druggability profile of stilbene-derived PPAR agonists: Determination of physicochemical properties and PAMPA study 129
Benzothiazole-based N-(phenylsulfonyl)amides as a novel familyof PPARa antagonists 128
null 128
Syntesis and pharmacological evaluation of fibrates analogues as cardiovascular agents 127
Sintesi e valutazione biologica di analoghi eterociclici del gemfibrozil a potenziale attività cardiovascolare 124
Indazole, Pyrazole, and Oxazole Derivatives Targeting Nitric Oxide Synthases and Carbonic Anhydrases 124
Synthesis and cytotoxic effects on pancreatic cancer cells of resveratrol analogs 123
Fibrate-derived N-(methylsulfonyl)amides with antagonistic properties on PPARa 122
Synthesis and biological evaluation of new acetamidines as selective inhibitors of Nitric Oxide Synthases 121
Synthesis of naphthyl-, quinolin- and anthracenyl analogues of clofibric acid as PPARα agonists 121
Enantiomeric separation of some demethylated analogues of clofibric acid by capillary zone electrophoresis and nano-liquid chromatography 118
Selective inhibition of inducible Nitric Oxide Synthase by derivatives of acetamidine 118
Sulfonimide and Amide Derivatives as Novel PPARα Antagonists: Synthesis, Antiproliferative Activity, and Docking Studies 116
Discovery of gemfibrozil analogues that activate PPARa and enhance the expression of gene CPT1A involved in fatty acids catabolism 114
Starting a new series of acetamidines as Nitric Oxide Sinthase inhibitors 113
Amidine-Based Compounds Affecting L-Arginine Metabolism 113
Novel aminobenzyl-acetamidine derivative modulate the differential regulation of NOSs in LPS induced inflammatory response: Role of PI3K/Akt pathway 113
Selective Acetamidine-Based Nitric Oxide Synthase Inhibitors: Synthesis, Docking, and Biological Studies 112
Time factor in antiretroviral adherence: analysis of adherence to single-tablet regimens versus multiple-tablet regimens over a 5-year period 112
Fibrate-based N-acylsulphonamides targeting carbonic anhydrases: synthesis, biochemical evaluation, and docking studies 111
Selective Inhibition of iNOS by Benzyl- and Dibenzyl Derivatives of N-(3-Aminobenzyl)acetamidine. 110
Synthesis and biological evaluation of novel acetamidines as nitric oxide inhibitors 109
N-Substituted acetamidines and 2-methylimidazole derivatives as selective inhibitors of neuronal nitric oxide synthase 109
Sintesi di esteri del gemfibrozil donatori di ossido nitrico 109
Amidine-Based Bioactive Compounds for the Regulation of Arginine Metabolism 107
Structural development studies of PPARs ligands based on tyrosine scaffold 107
Selective inhibition of iNOS by benzyl- and dibenzyl derivatives of N-(3-aminobenzyl)acetamidine on cellular line H2C9 106
Analoghi eterociclici dell’acido clofibrico: sintesi, attività antiaggregante piastrinica e separazione in elettroforesi capillare 104
Enantioseparazione di analoghi chirali dei fibrati in Elettroforesi Capillare e nano-Cromatografia Liquida 104
Synthesis, characterization and evaluation of gemfibrozil-stilbene hybrid as antioxidant agent 103
Dual-PPAR agonists based on stilbene scaffold: synthesis and biological evaluation 102
Effect of stilbene and chalcone scaffolds incorporation in clofibric acid on PPARα agonistic activity 100
Synthesis, biological evaluation, and docking study of indole aryl sulfonamides as aromatase inhibitors 100
Platelet aggregation: synthesis and pharmacological evaluation of clofibric acid analogues 97
Synthesis and cytotoxicity evaluation of novel amide and sulfonimide PPARa antagonists 97
Synthesis and pharmacological evaluation of gemfibrozil chiral analogues as cardiovascular agents 93
Novel Phenyldiazenyl Fibrate Analogues as PPAR Agonists: Design, Synthesis and Pharmacological Evaluation 93
Design, synthesis and biological evaluation of imidazole and triazole-based carbamates as novel aromatase inhibitors 93
In vitro protective effects of resveratrol and stilbene alkanoic derivatives on induced oxidative stress on c2c12 and mcf7 cells 92
Benzothiazole Derivatives Endowed with Antiproliferative Activity in Paraganglioma and Pancreatic Cancer Cells: Structure-Activity Relationship Studies and Target Prediction Analysis 91
Capillary electrophoretic enantioseparation of gemfibrozil analogues by use of TM-b-cyclodextrin as chiral selector 91
Synthesis of novel benzothiazole amides: Evaluation of PPAR activity and anti-proliferative effects in paraganglioma, pancreatic and colorectal cancer cell lines 91
Sintesi di derivati eterociclici dell’acido clofibrico a potenziale attività antiaggregante piastrinica 90
Design, synthesis and biological evaluation of novel acetamidines as selective inducible nitric oxide synthase inhibitors 89
Fibrate-Based Analogues as PPARs Agonists: Synthesis and Structure–Activity Relationships 88
Synthesis, structure-activity relationships and molecular docking studies of phenyldiazenyl sulfonamides as aromatase inhibitors 88
Azo derivatives of monoterpenes as anti-Helicobacter pylori agents: from synthesis to structure-based target investigation 87
Methods to Evaluate the Activity of Nitric Oxide Synthase 87
PPAR Ligands Containing Stilbene Scaffold 87
Reversed-phase high-performance liquid chromatography method with fluorescence detection to screen nitric oxide synthases inhibitors. 87
QSAR, QSPR and QSRR in terms of 3-D-MoRSE descriptors for in silico screening of clofibric acid analogues 86
Separazione enantiomerica di analoghi chirali dell'acido clofibrico mediante elettroforesi capillare 86
Design, synthesis and biological evaluation of aromatase inhibitors based on sulfonates and sulfonamides of resveratrol 86
Coumarin-Based Dual Inhibitors of Human Carbonic Anhydrases and Monoamine Oxidases Featuring Amino Acyl and (Pseudo)-Dipeptidyl Appendages: In Vitro and Computational Studies 82
Screening of NOS activity and selectivity of newly synthesized acetamidines using RP-HPLC 82
Synthetic Approach to Phenylalanine-Proline, and Tyrosine-Proline Hybrid Amino Acids 81
In vitro evaluation of a new selective iNOS inhibitor on normal rat astrocytes and C6 rat glioma cells 81
A Novel Prodrug of a nNOS Inhibitor with Improved Pharmacokinetic Potential 81
Geometric Isomerism of an Acetamidino Derivative Determined by NMR Investigations 80
Sintesi, relazioni struttura-attività e docking di nuovi inibitori delle Ossido Nitrico Sintasi 78
N-Acylsulfonylamides as a new class of PPARa antagonists 77
Enantiomeric separation of some chiral analogues of clofibric acid by capillary zone electrophoresis and nano-liquid chromatography 73
Antiviral Peptides as Anti-Influenza Agents 70
Development of CDK4/6 Inhibitors: A Five Years Update 69
Novel Synthetic Strategies for the Development of Tryptophan-Proline Chimeras, Useful Tool for Drug Discovery 65
Protein-protein interactions at a glance: Protocols for the visualization of biomolecular interactions 64
PPAR Ligands Induce Antiviral Effects Targeting Perturbed Lipid Metabolism during SARS-CoV-2, HCV, and HCMV Infection 64
HDAC Inhibitors for the Therapy of Triple Negative Breast Cancer 61
Synthesis, in vitro evaluation, and molecular modelling investigation of benzenesulfonimide Peroxisome Proliferator-Activated Receptors α antagonists 60
Benzenesulfonamide derivatives as Vibrio cholerae carbonic anhydrases inhibitors: a computational-aided insight in the structural rigidity-activity relationships 59
Pegylation approach applied to erlotinib–carbonic anhydrase inhibitors hybrids towards anticancer agents 56
New azolyl-derivatives as multitargeting agents against breast cancer and fungal infections: synthesis, biological evaluation and docking study 48
Resveratrol-based compounds and neurodegeneration: Recent insight in multitarget therapy 47
Resveratrol Analogues as Dual Inhibitors of Monoamine Oxidase B and Carbonic Anhydrase VII: A New Multi-Target Combination for Neurodegenerative Diseases? 46
Erlotinib-containing benzenesulfonamides as anti-Helicobacter pylori agents through carbonic anhydrase inhibition 43
A novel life for antitumor combretastatins: Recent developments of hybrids, prodrugs, combination therapies, and antibody-drug conjugates 42
A Comprehensive Computational Insight into the PD-L1 Binding to PD-1 and Small Molecules 41
Inhibition of Human Coronavirus 229E by Lactoferrin-Derived Peptidomimetics 30
Totale 10.317
Categoria #
all - tutte 39.800
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.800


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021380 0 0 0 0 0 110 14 44 90 72 11 39
2021/2022609 10 11 22 95 54 22 23 52 97 20 70 133
2022/20231.441 103 202 108 136 133 305 71 110 178 17 52 26
2023/2024693 51 21 61 14 43 216 166 10 4 30 9 68
2024/20251.645 73 303 268 21 38 90 64 96 161 73 237 221
2025/20262.005 309 129 444 514 478 131 0 0 0 0 0 0
Totale 10.345